Octagon Capital Advisors LP / VRNA
Octagon Capital Advisors LP’s Verona Pharma PLC Position
Does Octagon Capital Advisors LP own Verona Pharma PLC (VRNA)? Not currently — the last reported position was 337.0K shares worth $32M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$32M
Q2 2025
Shares
337.0K
% of Portfolio
+7.00%
Quarters Held
12
position exited
Position History VRNA
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2025 | 337.0K | $32M | +7.00% |
| Q1 2025 | 217.3K | $14M | +2.67% |
| Q4 2024 | 571.3K | $27M | +4.37% |
| Q3 2024 | 1.84M | $53M | +8.21% |
| Q2 2024 | 1.90M | $27M | +4.31% |
| Q1 2024 | 2.37M | $38M | +4.57% |
| Q4 2023 | 2.37M | $47M | +7.54% |
| Q3 2023 | 2.37M | $39M | +5.93% |
| Q2 2023 | 2.47M | $52M | +7.26% |
| Q1 2023 | 2.47M | $50M | +7.13% |
| Q4 2022 | 2.47M | $64M | +10.04% |
| Q3 2022 | 1.32M | $14M | +2.34% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Octagon Capital Advisors LP’s full portfolio or all institutional holders of VRNA.